News & Views

20th December 2017

Montreux Healthcare Fund agrees sale of The Regard Group

The Montreux Healthcare Fund PLC has agreed the sale of its primary asset, The Regard Group, to AMP Capital, a specialist investment manager. The Regard Group, which offers industry-­‐leading specialist care for adults with Learning Disabilities and Mental Health issues, operates an efficient business with industry leading care quality ratings and occupancy.

The Montreux Healthcare Fund, which is advised by Montreux Capital Management (UK), bought The Regard Group with Macquarie Principal Finance three years ago and has subsequently grown the business into a national provider of premier specialist service by bolting on complementary acquisitions, most notably Aitch Care Homes and Adelphi Care. Today, the Regard Group operates 161 specialist care facilities across the UK, employing more than 2,200 staff and providing dedicated support to more than 1,100 individuals.

Oliver Harris, CEO, Montreux Capital Management (UK) stated:
“This is the most significant deal in the sector this year, owing to the quality of the business we have built. Montreux has more than doubled the value of the business in three years, whilst delivering award winning care and levels of service. We are sure that The Regard Group will continue to go from strength to strength under its new ownership.”

Florian Herold, Co-­‐Head of Macquarie Principal Finance Europe, said:
“This sale marks the successful finish to an exciting journey for us which started over three years ago. Management’s outstanding work has driven substantial growth in the business while maintaining market leading quality care for its clients. It’s great to see that by working with our partner Montreux, our support and capital investment were able to contribute to this rewarding outcome for clients, staff and shareholders.”



For further information please contact:
Ben Robinson
KL Communications
(W): 0203 137 7821
(M): 07818 445 002

Notes to editors:

About Montreux Capital Management (UK)
Montreux Capital Management (UK) is the advisor to The Montreux Healthcare Fund, advising on UK centric specialist care transactions.

The Montreux Healthcare Fund
The Montreux Healthcare Fund focuses exclusively on investing in the specialist care space in the United Kingdom. Through the provision of quality care, the fund offers an opportunity to change the lives of some of the UK’s most vulnerable people while offering a solid, uncorrelated and truly alternative return for investors.

The Regard Group
The Regard Group is the majority owned asset of The Montreux Healthcare Fund and one of the largest specialist care businesses in the UK. It offers support to Adults with learning disabilities, acquired brain injuries and mental health disorders. Throughout the time that the company has been under the ownership of the fund, it has consistently won awards for the quality of its care and its innovative approach.

AMP Capital
AMP Capital is a specialist investment manager with A$178.9 billion in funds under management as of 30 June 2017 and more than 250 investment professionals. AMP Capital has a heritage and strength in real estate and infrastructure, and specialist expertise in fixed income, equities and multi-­‐asset solutions. It is a subsidiary of AMP Limited, which was established in 1849, and is one of Australia's largest retail and corporate pension providers.


The information on this site is intended only for the use of Independent Financial Advisors (IFAs) and other professionally recognised financial intermediaries & institutions.. Should you proceed to access this site, you will be representing and warranting that you are an IFA or other professionally recognised financial intermediary . What follows is not an offer or invitation to acquire an investment and should therefore not be relied upon by, any person in any jurisdiction where such an offer or invitation would be unlawful. Persons in respect of whom such prohibitions apply must not access this web site. None of the information contained on this site constitutes personal recommendations nor advice. Product details should always be read in conjunction with the appropriate offering documents. An application for any of the investment products on this page should be made having fully read not only the relevant application form, but also the relevant terms and conditions and offering documents. If you are unsure about the meaning of any information provided on this web page, then please consult your financial or other professional adviser. We do not offer investment advice.

This web site may contain or be linked to advice or statements of third parties. We make no representation as to the accuracy, completeness, timeliness or suitability of such information, and we have not and will not review or update such information and caution you that any use made of such information is at your own risk. Some of the information contained on this web site may also have been prepared or provided by third parties and may not have been verified by us. We hereby exclude any liability arising out of any preparation or provision of such information for the web site and makes no warranty as to the accuracy, suitability or completeness of any such information.

I agree, Continue

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together "the Sponsors," or "Sponsor) do not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

I agree, Continue